RB1 and triple-negative breast carcinoma: Interestingly, two recent studies carried out in RB-deficient small cell lung cancer cells [691] and triple-negative breast cancer cells [692] have shown that Aurora A or B kinase inhibition is synthetic lethal with loss of the RB1 tumor suppressor gene.